"Designing Growth Strategies is in our DNA"

Bronchitis Treatment Market Size, Share & Industry Analysis, By Types (Chronic Bronchitis, Acute Bronchitis), By Drug Class (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, Mucolytic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmaceutical Stores) and Regional Forecast, 2020-2027

Region : Global | Report ID: FBI103332 | Status : Ongoing

 

KEY MARKET INSIGHTS

Bronchitis is a medical condition that leads to inflammation of airways in the lungs (bronchial tubes), which cause coughing, generally with mucus. Symptoms of bronchitis include cough with mucus, dyspnea (shortness of breath), a whistling sound made while breathing, and chest pain. There are two basic types of bronchitis, acute and chronic. In developed as well as in developing countries, bronchitis is one of the most frequent respiratory diseases observed. The factors like smoking, bacterial infections, and repeated cold & flu that stimulate bronchitis are expected to drive the bronchitis treatment market growth.


Cigarette smoking is the most prominent cause of bronchitis and is likely to boost the market growth during the forecast period. According to American Lung Association (ALA) 2019, about 85 to 90 percent of all chronic obstructive pulmonary disease (COPD) cases are caused by cigarette smoking, which weakens the lung's defense against infections, narrow air passages, and cause swelling in the air tube. Moreover, an increase in the prevalence of COPD, which includes bronchitis majorly, is expected to boost the growth of the market. As per the World Health Organization (WHO) in 2017, approximately 251 million people in the world were likely to have COPD. It was also projected that in 2015, COPD caused 5% of all deaths globally. Furthermore, rising awareness and demand for safe & efficient treatment options related to bronchitis treatment & diagnosis expected to propel the market growth. Other risk factors such as a rising level of chemical pollutants, gastric reflux, occupational hazards like exposure to irritants such as chemicals, fumes, dust, and pollution are also likely to fuel the market growth.


However, stringent regulations regarding the release of drugs and the cost of approval are likely to hinder the market growth. 


Key Market Driver -

Cigarette smoking and an increase in the prevalence of bronchitis.

Key Market Restraint -

Stringent regulatory guidelines and high cost of drug approval.


Market Segmentation:


The global bronchitis treatment market can be segmented on the basis of types, drug class, distribution channel, and region. Based on the types, the market can be segmented into chronic bronchitis and acute bronchitis. Based on the drug class, the market can be segmented into antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytic. Based on the distribution channel, the market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies.


Geographically, the bronchitis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.


Key Players Covered:


The major companies in the global bronchitis treatment report include Dr. Reddy's Laboratories Ltd, Pfizer Inc., Sanofi, MELINTA THERAPEUTICS, INC., Pfizer Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Novartis AG, and other prominent players.


Key Insights:



  • New Drug Launch

  • Prevalence of Bronchitis for Key Countries

  • Recent Bronchitis Treatment Research & Development Activities

  • Key Industry Developments - Mergers, Acquisitions, and Partnerships


Regional Analysis:


Geographically, the global bronchitis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for a significant share of the global bronchitis treatment market owing to the high prevalence of bronchitis, awareness regarding health among people, and well-established healthcare infrastructure and facilities. Europe is expected to hold the second-largest share of the market. The growth of the market in this region is due to the increased prevalence of chronic diseases, increasing healthcare expenditure by the European Commission, and rising awareness in people regarding health. However, the Asia-Pacific region is expected to hold the enormous potential to show considerable market growth during the forecast period. This growth in the region can be attributed to the increasing trend of smoking in the young generation, rising prevalence of chronic illness, the growing geriatric population in the region, escalation in the air pollution, and increase in the healthcare expenditure and facilities. Latin America and the Middle East & Africa are increasing steadily in the market.


To gain extensive insights into the market, Request for Customization


Segmentation


























 ATTRIBUTE


  DETAILS

By Types




  • Chronic Bronchitis

  • Acute Bronchitis



By Drug Class




  • Antibiotics

  • Anti-Inflammatory Drugs

  • Bronchodilators

  • Mucolytic



By Distribution Channel




  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmaceutical Stores



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Bronchitis Treatment Market Industry Developments



  • July 2018 GlaxoSmithKline plc announced the outcome of the Pulmonary Allergy Drugs Advisory Committee of the United States (US) Food and Drug Administration (FDA) meeting on the use of mepolizumab as an add-on treatment to inhaled corticosteroid-based maintenance treatment for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD) guided by blood eosinophil counts.

  • In February 2020, Pfizer Inc. announced to continue the trial of azithromycin sr for the treatment of acute bronchitis and secondary infection of chronic respiratory diseases


Bronchitis Treatment Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Logo_Merck_KGaA_2015
Ge-Healthcare
Bio-Rad
DAEWOONG
lpsos

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X